Moderna Shares Crater on Huge Revenue Miss, Massive Guidance Cut

    0
    87

    Vaccine giant’s shares plunge 10% amid reports of rare side effects, new government restrictions, production struggles

    Advertisment
    Previous article8,500 Active-Duty Air Force Troops Miss Vaccine Mandate Deadline
    Next articleThe United Nations Could Finally Create New Rules For Space

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here